PROCEPT BioRobotics Reports Q3 2025 Earnings with Revenue Growth and Improved Gross Margin
PROCEPT BioRobotics (PRCT) reported Q3 2025 earnings with total revenue of $83.3 million, reflecting 43% year-over-year growth. The company also noted a 160 basis point increase in gross margin to 64.8%, driven by organizational effectiveness, though it still reported a net loss of $21.4 million. The results highlight strong U.S. revenue growth and improved financial efficiency.
Topics: Earnings Report Financial Performance Gross Margin Guidance Operating Expenses Revenue Growth